Clinical Trials match your criteria
-
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
-
Combo Chemo w/ or w/o Torisel Treating Rhabdomyosarcoma
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
-
NMTT- Neuroblastoma Maintenance Therapy Trial Using DFMO
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
-
Craniopharyngioma - Identifying Bio Targets for Medical Therapy
Advancing Treatment for Pediatric Craniopharyngioma: Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
-
Project:EveryChild - A Registry, Eligibility Screening, Biology and Outcome Study
Project: EveryChild a Registry, Eligibility Screening, Biology and Outcome Study
-
Response & Biology Based Risk Factor Guided Therapy Treating Patients w/Non-high Risk Neuroblastoma
Utilizing Response and Biology Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma
-
Study That Examines the Mental and Behavioral Outcomes in Younger Patients With Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer
-
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Umbrella Long-Term Follow-Up Protocol
-
International Registry for Severe Chronic Neutropenia
Severe Chronic Neutropenia International Registry